Aadi Bioscience, Inc. (AADI) Reports In-Line Q3 EPS

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q3 EPS of ($0.46), in-line with the analyst estimate of ($0.46). Revenue for the quarter came in at $7.21 million versus the consensus estimate of $6.59 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue
• Blue Moon Metals reports assay results from Nevada tungsten project
• Barksdale plans C$14M placement, name change, and leadership overhaul